Daniel Lowenstein, MD
Daniel (Dan) Lowenstein was appointed executive vice chancellor and provost (EVCP) effective February 1, 2015. Read the UCSF news announcement. Dr. Daniel H. Lowenstein is the Robert B. and Ellinor Aird Professor. He received his B.A. degree in Mathematics from the University of Colorado in 1973, an M.S. degree in Man-Environment Relations from The Pennsylvania State University in 1978, and an M.D. degree from Harvard Medical School in 1983.
Brian Alldredge, PharmD
Brian Alldredge is vice provost for academic affairs. He earned his BS in Chemistry from UCLA and his PharmD from UCSF. He is a clinician-educator-researcher with research and clinical interests in epilepsy, seizure emergencies, and pharmacogenomics. He holds joint academic appointments in the Department of Clinical Pharmacy, School of Pharmacy, and in the Department of Neurology, School of Medicine. He is responsible for supervision of academic appointment, advancement and review processes; oversight of academic policy development and implementation; and he plays a key role in developing programs for faculty welfare, development and growth.
Janhavi Bonville, MPP
Janhavi Bonville is associate EVCP. Her role includes managing strategic initiatives for the EVCP office as well as presentations, communications, and all critical projects. She came from a strategy management consulting and corporate healthcare background, working for Accenture and UnitedHealthcare. She has a master's degree in Public Policy from UC Berkeley and a B.A. from Columbia. Team members.
Jennifer R. Grandis, MD
Jennifer (Jenny) Grandis was appointed associate vice chancellor—clinical and translational research, and professor of otolaryngology—head and neck surgery effective February 1, 2015. She earned her BA in Art History and Biology from Swarthmore College and her MD from the University of Pittsburgh. She came to UCSF from the University of Pittsburgh where she served as assistant vice chancellor for research program integration in the health sciences. Her research focuses on signal transduction with an emphasis on precision medicine approaches to head and neck cancer. She is an American Cancer Society Clinical Research Professor and a member of the American Society for Clinical Investigation, the American Association of Physicians, and the Institute of Medicine of the National Academies.
Mylo Schaaf, MD, MPH, DTMH
Mylo Schaaf is the Director of Global Outreach for the EVCP. She manages international affiliation issues and is also the Assistant Director of the Pathways for Global Health at UCSF. She received her BA degree in Journalism and her MPH from the University of California at Berkeley, her MD from Harvard University, and her DTMH from the London School of Tropical Medicine and Hygiene. Dr. Schaaf trained and is certified in Internal Medicine through the Division of General Internal Medicine at UCSF. She has worked in clinical care and teaching in a number of countries in Asia, Africa, and Latin America.
Elizabeth Watkins, PhD
Elizabeth (Liz) Watkins earned her BA in Biology and PhD in the History of Science both at Harvard University and is Vice Chancellor—Student Academic Affairs, Dean of the Graduate Division, and Professor in the Department of Anthropology, History, and Social Medicine. Her research focuses on the interrelations of medicine, science, commerce, and culture in the U.S. in the twentieth and twenty-first centuries, and she has published on the topics of the history of prescription drugs; birth control; estrogen and female aging; testosterone and male aging; and stress and disease. Her work has been funded by NSF, NIH, the National Endowment for the Humanities, and the National Academy of Education.
Keith R. Yamamoto, PhD
Keith Yamamoto is vice chancellor for research, professor of cellular and molecular pharmacology, and executive vice dean of the School of Medicine. After earning his PhD degree at Princeton University, he came to UCSF as a postdoc in 1973, starting on the faculty in 1976. A key player in shaping national science policy, he is regarded as an international leader in studying the mechanisms of signaling and gene regulation by intracellular receptors. He leads campus efforts to advance innovative, collaborative and interdisciplinary approaches to research across the university’s schools and graduate programs with the goal to advance UCSF into a new era of fundamental discovery, together with an understanding of health and disease.